Of note, this study revealed a cancer-associated truncated version of MASTL, referred to as MASTL450 (Figure 1a) that displays catalytic activity, not on Arpp19 or ENSA, but on novel substrates, such as high mobility group protein A1 (HMGA1), which has been linked to the metastatic progression of cancer cells. Here, HMGA1 is linked to cancer.